Delayed melanoma diagnosis in the COVID-19 era: increased breslow thickness in primary melanomas seen after the COVID-19 lockdown
- PMID: 32780876
- PMCID: PMC7436601
- DOI: 10.1111/jdv.16874
Delayed melanoma diagnosis in the COVID-19 era: increased breslow thickness in primary melanomas seen after the COVID-19 lockdown
Conflict of interest statement
Not declared by any author.
Comment in
-
Melanoma of unknown primary: a case series.Ir J Med Sci. 2023 Feb;192(1):65-66. doi: 10.1007/s11845-022-02951-w. Epub 2022 Feb 17. Ir J Med Sci. 2023. PMID: 35175465 Free PMC article. No abstract available.
References
-
- Gershenwald JE, Scolyer RA. Melanoma staging: American Joint Committee on Cancer (AJCC) 8th edition and beyond. Ann Surg Oncol 2018; 25: 2105–2110. - PubMed
-
- Esserman LJ, Thompson IM, Jr , Reid B. Overdiagnosis and overtreatment in cancer: an opportunity for improvement. JAMA 2013; 310: 797–798. - PubMed
-
- Sacchetto L, Zanetti R, Comber H et al. Trends in incidence of thick, thin and in situ melanoma in Europe. Eur J Cancer 2018; 92: 108–118. - PubMed
-
- Gomolin T, Cline A, Handler MZ. The danger of neglecting melanoma during the COVID‐19 pandemic. Dermatolog Treat 2020; 31: 444–445. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
